Interval Cancers in a Population-Based Screening Program for Colorectal Cancer in Catalonia, Spain

Author:

Garcia M.1,Domènech X.1,Vidal C.1,Torné E.2,Milà N.13,Binefa G.13,Benito L.14,Moreno V.135

Affiliation:

1. Cancer Prevention and Control Program, Catalan Institute of Oncology, IDIBELL, L’Hospitalet de Llobregat, 08908 Barcelona, Spain

2. Barcelona Health Region, CatSalut, 08023 Barcelona, Spain

3. Consortium for Biomedical Research in Epidemiology and Public Health (CIBEResp), 28029 Madrid, Spain

4. Department of Fundamental Care and Medical-Surgical Nursing, University of Barcelona, L’Hospitalet de Llobregat, 08907 Barcelona, Spain

5. Department of Clinical Sciences, University of Barcelona, L’Hospitalet de Llobregat, 08907 Barcelona, Spain

Abstract

Objective. To analyze interval cancers among participants in a screening program for colorectal cancer (CRC) during four screening rounds.Methods. The study population consisted of participants of a fecal occult blood test-based screening program from February 2000 to September 2010, with a 30-month follow-up (n= 30,480). We used hospital administration data to identify CRC. An interval cancer was defined as an invasive cancer diagnosed within 30 months of a negative screening result and before the next recommended examination. Gender, age, stage, and site distribution of interval cancers were compared with those in the screen-detected group.Results. Within the study period, 97 tumors were screen-detected and 74 tumors were diagnosed after a negative screening. In addition, 17 CRC (18.3%) were found after an inconclusive result and 2 cases were diagnosed within the surveillance interval (2.1%). There was an increase of interval cancers over the four rounds (from 32.4% to 46.0%). When compared with screen-detected cancers, interval cancers were found predominantly in the rectum (OR: 3.66; 95% CI: 1.51–8.88) and at more advanced stages (P=0.025).Conclusion. There are large numbers of cancer that are not detected through fecal occult blood test-based screening. The low sensitivity should be emphasized to ensure that individuals with symptoms are not falsely reassured.

Funder

Carlos III Health Institute

Publisher

Hindawi Limited

Subject

Gastroenterology,Hepatology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3